Prof. Dr. med. Arndt Hartmann



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fully automatic HER2 tissue segmentation for interpretable HER2 scoring (2025) Öttl M, Steenpaß J, Wilm F, Qiu J, Rübner M, Lang-Schwarz C, Taverna C, et al. Journal article Machine Learning Accurately Predicts Muscle Invasion of Bladder Cancer Based on Three miRNAs (2025) Eckhart L, Rau S, Eckstein M, Stahl PR, Ayoubian H, Heinzelbecker J, Zohari F, et al. Journal article Neues aus der Uropathologie (2025) Hartmann A Journal article Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women (2025) Stübs F, Dietl A, Schulmeyer C, Behrens A, Seibold A, Brückner L, Schleicher O, et al. Journal article PD-L1-Expression in in primary and recurrent vulvar squamous cell cancer (2025) Stübs F, Knöll A, Hartmann A, Leikauf LS, Matek C, John N, Häberle L, et al. Journal article Peniskarzinom: Die Bedeutung der histologischen Klassifikation und neue Behandlungsansätze (2025) Fiegl A, Mink JN, Junker K, Linxweiler J, Hartmann A Journal article, Review article Effects of different B-cell-depleting strategies on the lymphatic tissue (2025) Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, et al. Journal article Mast cells infiltrates are common in eosinophilic esophagitis and still elevated in histological remission: A digital evaluation in children (2025) Hironimus T, Degen S, Rappl A, Allabauer I, Wölfle J, Hartmann A, Bruns V, et al. Journal article Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer (2025) Gloßner L, Eckstein M, Mark C, Beckmann M, Hartmann A, Strissel P, Strick R Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article